Ramsay Générale de Santé SA (GDS.PA)
EUR 9.72
(0.21%)
EUR 9.72
(0.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.66 Billion EUR | -0.27% |
| 2022 | 5.68 Billion EUR | 2.37% |
| 2021 | 5.54 Billion EUR | -0.61% |
| 2020 | 5.58 Billion EUR | -1.66% |
| 2019 | 5.67 Billion EUR | 70.86% |
| 2018 | 3.32 Billion EUR | 66.89% |
| 2017 | 1.99 Billion EUR | 7.99% |
| 2016 | 1.84 Billion EUR | -3.77% |
| 2015 | 1.91 Billion EUR | 36.02% |
| 2014 | 1.4 Billion EUR | 23.41% |
| 2013 | 1.14 Billion EUR | -17.68% |
| 2012 | 1.38 Billion EUR | -6.44% |
| 2011 | 1.48 Billion EUR | -1.65% |
| 2010 | 1.5 Billion EUR | -2.05% |
| 2009 | 1.53 Billion EUR | -5.37% |
| 2008 | 1.62 Billion EUR | -1.16% |
| 2007 | 1.64 Billion EUR | 50.95% |
| 2006 | 1.08 Billion EUR | -4.37% |
| 2005 | 1.13 Billion EUR | 26.35% |
| 2004 | 901.8 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 5.66 Billion EUR | -0.27% |
| 2023 Q2 | 5.59 Billion EUR | 0.0% |
| 2023 Q3 | 5.74 Billion EUR | 2.79% |
| 2023 Q4 | 5.66 Billion EUR | -1.44% |
| 2023 Q1 | 5.59 Billion EUR | -1.56% |
| 2022 Q2 | 5.72 Billion EUR | 0.0% |
| 2022 Q3 | 5.68 Billion EUR | -0.72% |
| 2022 Q4 | 5.68 Billion EUR | 0.0% |
| 2022 FY | 5.68 Billion EUR | 2.37% |
| 2022 Q1 | 5.72 Billion EUR | 3.11% |
| 2021 FY | 5.54 Billion EUR | -0.61% |
| 2021 Q1 | 5.38 Billion EUR | -3.53% |
| 2021 Q4 | 5.54 Billion EUR | 0.0% |
| 2021 Q2 | 5.38 Billion EUR | 0.0% |
| 2021 Q3 | 5.54 Billion EUR | 3.03% |
| 2020 Q3 | 5.58 Billion EUR | -2.04% |
| 2020 Q1 | 5.69 Billion EUR | 0.39% |
| 2020 Q2 | 5.69 Billion EUR | 0.0% |
| 2020 Q4 | 5.58 Billion EUR | 0.0% |
| 2020 FY | 5.58 Billion EUR | -1.66% |
| 2019 Q2 | 5.18 Billion EUR | 0.0% |
| 2019 FY | 5.67 Billion EUR | 70.86% |
| 2019 Q1 | 5.18 Billion EUR | 56.12% |
| 2019 Q3 | 5.67 Billion EUR | 9.44% |
| 2019 Q4 | 5.67 Billion EUR | 0.0% |
| 2018 FY | 3.32 Billion EUR | 66.89% |
| 2018 Q4 | 3.32 Billion EUR | 0.0% |
| 2018 Q3 | 3.32 Billion EUR | -11.56% |
| 2018 Q2 | 3.75 Billion EUR | 0.0% |
| 2018 Q1 | 3.75 Billion EUR | 88.71% |
| 2017 Q1 | 1.88 Billion EUR | 2.47% |
| 2017 Q4 | 1.99 Billion EUR | 0.0% |
| 2017 Q3 | 1.99 Billion EUR | 5.38% |
| 2017 Q2 | 1.88 Billion EUR | 0.0% |
| 2017 FY | 1.99 Billion EUR | 7.99% |
| 2016 FY | 1.84 Billion EUR | -3.77% |
| 2016 Q4 | 1.84 Billion EUR | 0.0% |
| 2016 Q3 | 1.84 Billion EUR | -0.84% |
| 2016 Q2 | 1.85 Billion EUR | 0.0% |
| 2016 Q1 | 1.85 Billion EUR | -2.95% |
| 2015 FY | 1.91 Billion EUR | 36.02% |
| 2015 Q2 | 1.83 Billion EUR | 0.0% |
| 2015 Q3 | 1.91 Billion EUR | 4.37% |
| 2015 Q4 | 1.91 Billion EUR | 0.0% |
| 2015 Q1 | 1.83 Billion EUR | 0.0% |
| 2014 Q2 | 1.37 Billion EUR | 17.94% |
| 2014 Q1 | 1.16 Billion EUR | -0.15% |
| 2014 FY | 1.4 Billion EUR | 23.41% |
| 2013 Q2 | 1.14 Billion EUR | -17.73% |
| 2013 Q1 | 1.38 Billion EUR | -1.58% |
| 2013 FY | 1.14 Billion EUR | -17.68% |
| 2013 Q4 | 1.17 Billion EUR | 2.64% |
| 2013 Q3 | 1.14 Billion EUR | -0.06% |
| 2012 FY | 1.38 Billion EUR | -6.44% |
| 2012 Q2 | 1.38 Billion EUR | -3.27% |
| 2012 Q1 | 1.43 Billion EUR | -4.45% |
| 2012 Q4 | 1.4 Billion EUR | 0.13% |
| 2012 Q3 | 1.4 Billion EUR | 1.53% |
| 2011 Q1 | 1.53 Billion EUR | 0.17% |
| 2011 Q4 | 1.5 Billion EUR | -0.85% |
| 2011 Q3 | 1.51 Billion EUR | 2.11% |
| 2011 FY | 1.48 Billion EUR | -1.65% |
| 2011 Q2 | 1.48 Billion EUR | -3.41% |
| 2010 FY | 1.5 Billion EUR | -2.05% |
| 2010 Q4 | 1.53 Billion EUR | 0.11% |
| 2010 Q3 | 1.53 Billion EUR | 1.53% |
| 2010 Q2 | 1.5 Billion EUR | -2.47% |
| 2010 Q1 | 1.54 Billion EUR | 0.0% |
| 2009 Q2 | 1.53 Billion EUR | 0.0% |
| 2009 FY | 1.53 Billion EUR | -5.37% |
| 2008 FY | 1.62 Billion EUR | -1.16% |
| 2007 FY | 1.64 Billion EUR | 50.95% |
| 2006 FY | 1.08 Billion EUR | -4.37% |
| 2005 FY | 1.13 Billion EUR | 26.35% |
| 2004 FY | 901.8 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Clariane SE | 11.24 Billion EUR | 49.611% |
| LNA Santé SA | 1.19 Billion EUR | -372.669% |